Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verona Pharma PlcADS | 538,488 | 924,204 | +385,716 | $34.19M | $87.41M | 22.48% | +$53.22M |
| Insmed Incorporated(INSM) | 318,239 | 752,712 | +434,473 | $24.28M | $75.75M | 19.48% | +$51.47M |
| argenx SEADR(ARGX) | 11,311 | 78,311 | +67,000 | $6.69M | $43.17M | 11.10% | +$36.47M |
| Soleno Therapeutics Inc | 498,473 | 494,424 | -4,049 | $35.62M | $41.42M | 10.65% | +$5.81M |
| Eli Lilly and Company(LLY) | 94,887 | 30,700 | -64,187 | $78.37M | $23.93M | 6.15% | -$54.44M |
| Boston Scientific Corporation(BSX) | 129,700 | 155,200 | +25,500 | $13.08M | $16.67M | 4.29% | +$3.59M |
| Merus N V | 424,640 | 296,750 | -127,890 | $17.87M | $15.61M | 4.01% | -$2.26M |
| Quest Diagnostics Incorporated(DGX) | 56,717 | 81,717 | +25,000 | $9.60M | $14.68M | 3.78% | +$5.08M |
| AstraZeneca PLCADR(AZN) | 190,752 | 190,752 | 0 | $14.02M | $13.33M | 3.43% | -$690.5K |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 1,311,840 | +1,311,840 | $0 | $7.18M | 1.85% | +$7.18M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 28,600 | 20,970 | -7,630 | $7.72M | $6.84M | 1.76% | -$884.5K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 10,671 | +10,671 | $0 | $5.60M | 1.44% | +$5.60M |
| Scholar Rock Holding Corporation(SRRK) | 172,185 | 126,285 | -45,900 | $5.54M | $4.47M | 1.15% | -$1.06M |
| Revolution Medicines, Inc.(RVMD) | 104,190 | 104,190 | 0 | $3.68M | $3.83M | 0.99% | +$149.0K |
| Springworks Therapeutics Inc | 53,930 | 63,930 | +10,000 | $2.38M | $3.00M | 0.77% | +$624.1K |
| EyePoint, Inc.(EYPT) | 316,700 | 316,700 | 0 | $1.72M | $2.98M | 0.77% | +$1.26M |
| AbbVie Inc.(ABBV) | 0 | 14,500 | +14,500 | $0 | $2.69M | 0.69% | +$2.69M |
| Viking Therapeutics, Inc.(VKTX) | 90,279 | 96,479 | +6,200 | $2.18M | $2.56M | 0.66% | +$376.5K |
| Ascendis Pharma A/SADR(ASND) | 7,440 | 12,240 | +4,800 | $1.16M | $2.11M | 0.54% | +$953.0K |
| TG Therapeutics, Inc.(TGTX) | 54,515 | 54,515 | 0 | $2.15M | $1.96M | 0.50% | -$187.5K |
| Vertex Pharmaceuticals Incorporated(VRTX) | 0 | 4,400 | +4,400 | $0 | $1.96M | 0.50% | +$1.96M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 41,830 | +41,830 | $0 | $1.52M | 0.39% | +$1.52M |
| United Therapeutics Corporation(UTHR) | 5,000 | 5,000 | 0 | $1.54M | $1.44M | 0.37% | -$104.6K |
| Mereo BioPharma Group plcADS(MREO) | 421,359 | 475,361 | +54,002 | $948.1K | $1.29M | 0.33% | +$340.2K |
| Protagonist Therapeutics Inc | 333,851 | 22,951 | -310,900 | $16.15M | $1.27M | 0.33% | -$14.88M |
| Xenon Pharmaceuticals Inc.(XENE) | 40,000 | 40,000 | 0 | $1.34M | $1.25M | 0.32% | -$90.0K |
| Biohaven Ltd.(BHVN) | 0 | 80,000 | +80,000 | $0 | $1.13M | 0.29% | +$1.13M |
| Avidity Biosciences Inc | 0 | 34,600 | +34,600 | $0 | $982.6K | 0.25% | +$982.6K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 29,200 | +29,200 | $0 | $808.0K | 0.21% | +$808.0K |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 41,100 | +41,100 | $0 | $556.1K | 0.14% | +$556.1K |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 27,319 | +27,319 | $0 | $494.7K | 0.13% | +$494.7K |
| Janux Therapeutics, Inc.(JANX) | 38,100 | 20,000 | -18,100 | $1.03M | $462.0K | 0.12% | -$566.7K |
| Travere Therapeutics, Inc.(TVTX) | 30,900 | 30,900 | 0 | $553.7K | $457.3K | 0.12% | -$96.4K |
| Arcellx Inc COMMON STOCK | 229,085 | 0 | -229,085 | $15.03M | $0 | — | -$15.03M |
| Centessa Pharmaceuticals PlcADS | 35,226 | 0 | -35,226 | $506.6K | $0 | — | -$506.6K |
| Intra-Cellular Therapies Inc | 219,719 | 0 | -219,719 | $28.99M | $0 | — | -$28.99M |
| Intuitive Surgical, Inc.(ISRG) | 3,500 | 0 | -3,500 | $1.73M | $0 | — | -$1.73M |
| Neurocrine Biosciences, Inc.(NBIX) | 14,700 | 0 | -14,700 | $1.63M | $0 | — | -$1.63M |
| Nuvalent Inc | 90,745 | 0 | -90,745 | $6.44M | $0 | — | -$6.44M |
| Oruka Therapeutics, Inc.(ORKA) | 7,380 | 0 | -7,380 | $75.7K | $0 | — | -$75.7K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 50,000 | 0 | -50,000 | $2.65M | $0 | — | -$2.65M |
| Viridian Therapeutics, Inc.(VRDN) | 160,000 | 0 | -160,000 | $2.16M | $0 | — | -$2.16M |